Understanding pain in depression

Human Psychopharmacology
Stephen M Stahl, Mike Briley

Abstract

A dysfunction of the serotonergic and noradrenergic pathways is commonly accepted as playing a major role in the aetiology of depression. Serotonergic cell bodies, located in the raphe nucleus, send projections to various parts of the brain where they are involved in the control of mood, movement, emotions such as anxiety and regulate behaviours such as eating, sexual activity and the feeling of pleasure. Similarly, the noradrenergic neurons, located in the locus coeruleus, project to the same regions where they regulate, in addition, attention and cognition. A further projection to the cerebellum regulates motor control. A dysfunction at the level of the monoamine neurons thus results in the classical symptoms of depression. In addition to these ascending pathways, however, the neurons in the raphe nucleus and the locus ceruleus also project to the spinal cord. These descending pathways serve to inhibit input from the intestines, the skeletal muscles and other sensory inputs. Under normal conditions, these inhibitory effects are modest, but in times of stress, in the interests of the survival of the individual, they can completely inhibit the input from painful stimuli. A dysfunction at the level of the serotonergic and noradr...Continue Reading

References

May 1, 1993·The American Journal of Psychiatry·L J KirmayerM J Yaffe
Sep 1, 1996·International Clinical Psychopharmacology·J Lopez-IborJ F Prost
Jul 22, 1998·The Journal of Clinical Psychiatry·S E Byrne, A J Rothschild
Oct 28, 1999·The New England Journal of Medicine·G E SimonJ Ormel
Mar 7, 2001·The British Journal of Psychiatry : the Journal of Mental Science·M E ThaseR L Rudolph
May 11, 2001·Annals of Internal Medicine·L A Aaron, D Buchwald
May 17, 2001·International Clinical Psychopharmacology·G Clerc, UNKNOWN Milnacipran/Fluvoxamine Study Group
Aug 8, 2001·The Journal of Clinical Psychiatry·S M Stahl
Sep 20, 2001·The Journal of Clinical Psychiatry·S M Stahl
Feb 13, 2002·The Journal of Clinical Psychiatry·Stephen M Stahl
Jan 7, 2003·Archives of General Psychiatry·Maurice M Ohayon, Alan F Schatzberg
Feb 13, 2003·Archives of General Psychiatry·James I HudsonMing T Tsuang
Apr 23, 2004·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·D A FishbainR S Rosomoff

❮ Previous
Next ❯

Citations

Feb 22, 2012·European Child & Adolescent Psychiatry·Terhi LuntamoPatrick J McGrath
Apr 1, 2006·Acta Neuropsychiatrica·Lana J WilliamsMichael Berk
Sep 1, 2006·Neuropsychiatric Disease and Treatment·Akira Toyofuku, Toshihiro Kikuta
Mar 4, 2014·Experimental Brain Research·Antonio Rodríguez-GaztelumendiAlvaro Díaz
Jan 24, 2009·Clinical Rheumatology·Leonid Kalichman
Apr 11, 2009·Social Psychiatry and Psychiatric Epidemiology·Katja BeesdoHans-Ulrich Wittchen
Feb 13, 2016·The Journal of Pain : Official Journal of the American Pain Society·Marco HermesdorfHeike Wersching
Dec 23, 2014·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Erik J A ScherderJoukje M Oosterman
Apr 10, 2013·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Taro MurakamiKaoru Kurisu
Nov 6, 2012·Neuroscience Letters·Aya NakaeTakashi Mashimo
Jan 26, 2010·The Journal of Pain : Official Journal of the American Pain Society·Miao ShiFei Luo
May 12, 2009·Progress in Neurobiology·Jonathan SavitzWayne C Drevets
Aug 4, 2015·Journal of the Neurological Sciences·Sandro Zambito MarsalaMichele Tinazzi
Nov 4, 2008·The Journal of Nutritional Biochemistry·Takashi YamadaHidehiko Yokogoshi
Nov 4, 2008·La Presse médicale·Antoine Pelissolo
Nov 30, 2007·Neuroscience Research·Aya NakaeTakashi Mashimo
Jul 31, 2007·Journal of Psychosomatic Research·Mustafa M HusainMaurizio Fava
Dec 6, 2006·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·Gary D Klasser, Reny de Leeuw
May 30, 2009·Human Psychopharmacology·Stephen M Stahl, Mike Briley
May 30, 2009·Human Psychopharmacology·Siegfried Kasper
May 1, 2008·The European Journal of Neuroscience·Aya NakaeTakashi Masimo
Oct 30, 2007·Pharmacotherapy·Michael W Jann, Julian H Slade
Apr 15, 2008·Journal of Oral Rehabilitation·E ScherderF Lobbezoo
Nov 2, 2007·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·P KarlingK-F Norrback
Mar 14, 2007·Best Practice & Research. Clinical Rheumatology·Stefan Bergman
Mar 7, 2006·Journal of Affective Disorders·Koen DemyttenaereJordi Alonso
Oct 29, 2015·Journal of Neurogastroenterology and Motility·Pontus KarlingKarl-Fredrik Norrback
Aug 21, 2014·European Child & Adolescent Psychiatry·Marit SkroveMarit S Indredavik
Jan 20, 2010·Journal of Affective Disorders·Jochen GensichenJuliana J Petersen
Oct 21, 2014·PloS One·Eric W de HeerChristina M van der Feltz-Cornelis
Dec 24, 2010·The International Journal of Social Psychiatry·Kaustav ChakrabortySandeep Grover
May 27, 2006·Journal of Psychiatric Practice·Manpreet K SinghHenry A Nasrallah
Aug 26, 2006·Nature Clinical Practice. Rheumatology·Robert Bennett, David Nelson
May 5, 2012·Neuroreport·Guillaume HacheFrançois Coudoré

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.